Stock 4169 TCM BIOTECH INTERNATIONAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company TCM Biotech International Corp.

Equities

4169

TW0004169008

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
55.7 TWD -0.36% Intraday chart for TCM Biotech International Corp. +10.08% -4.30%
Apr. 16 TCM Biotech International Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 TCM Biotech International Corp. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

TCM BIOTECH INTERNATIONAL CORP. is a Taiwan-based company principally engaged in the detection and development of new medicine for liver disease. The Company's main businesses include the development of new medicine, which are mainly used for the treatment of hepatitis C and non-alcoholic fatty liver and other disease, manufacture and sales of dietary supplements and botanical raw materials, the sales of western medicine products and medical equipment, which are mainly used for the treatment of orthopedic disorders, cardiovascular disorders, oncology disorders and others, sales agent of organic products. The Company distributes its products both in domestic markets and to overseas markets.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Pharmaceutical
93.4 %
721 89.9 % 906 93.4 % +25.62%
Functional Food
6.5 %
62 7.8 % 63 6.5 % +1.57%
Other
0.1 %
19 2.4 % 0 0.1 % -97.41%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
99.9 %
784 97.7 % 968 99.9 % +23.55%
Other
0.1 %
19 2.3 % 1 0.1 % -93.50%

Managers

Managers TitleAgeSince
Ya Chun Wang CEO
 Chief Executive Officer - -
Shu Ya Yang DFI
 Director of Finance/CFO - 08-08-25
Huan Ching Hsu CHM
 Chairman - 10-06-22

Members of the board

Members of the board TitleAgeSince
Wen Yu Chiang BRD
 Director/Board Member - 12-02-14
Huan Ching Hsu CHM
 Chairman - 10-06-22
I Fang Hsu BRD
 Director/Board Member - -
Ya Chun Wang CEO
 Chief Executive Officer - -
Tzu Pei Chen BRD
 Director/Board Member - 12-10-29
Yung Lu Kuo BRD
 Director/Board Member - 12-02-14
Chih Yang Huang BRD
 Director/Board Member - 12-02-14
Chun Hsin Tsou BRD
 Director/Board Member - 17-06-26
Chin Chi Chen BRD
 Director/Board Member - 20-06-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 59,048,000 58,458,125 ( 99.00 %) 0 99.00 %

Company contact information

TCM Biotech International Corp.

24F, -8 No. 97, Section 1, Xintai 5th Road

221416, New Taipei

+

http://www.tcmbio.com
address TCM Biotech International Corp.(4169)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for TCM Biotech International Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
55.7 TWD
Average target price
113 TWD
Spread / Average Target
+102.87%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TCM BIOTECH INTERNATIONAL CORP. Stock TCM Biotech International Corp.
-4.30% 101M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4169 Stock
  4. Company TCM Biotech International Corp.